192 related articles for article (PubMed ID: 34015892)
1. Patterns of Proton Beam Therapy Use in Clinical Practice between 2007 and 2019 in Korea.
Lee SU; Yang K; Moon SH; Suh YG; Yoo GS
Cancer Res Treat; 2021 Oct; 53(4):935-943. PubMed ID: 34015892
[TBL] [Abstract][Full Text] [Related]
2. Insurance Approval for Proton Beam Therapy and its Impact on Delays in Treatment.
Gupta A; Khan AJ; Goyal S; Millevoi R; Elsebai N; Jabbour SK; Yue NJ; Haffty BG; Parikh RR
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):714-723. PubMed ID: 30557673
[TBL] [Abstract][Full Text] [Related]
3. A population-based assessment of proton beam therapy utilization in California.
Parikh-Patel A; Morris CR; Maguire FB; Daly ME; Kizer KW
Am J Manag Care; 2020 Feb; 26(2):e28-e35. PubMed ID: 32059097
[TBL] [Abstract][Full Text] [Related]
4. Young Adult Populations Face Yet Another Barrier to Care With Insurers: Limited Access to Proton Therapy.
Bishop AJ; Livingston JA; Ning MS; Valdez ID; Wages CA; McAleer MF; Paulino AC; Grosshans DR; Woodhouse KD; Tao R; Roth ME; Gunn GB; McGovern SL
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1496-1504. PubMed ID: 33677051
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Proton Beam Therapy Use Among Patients With Newly Diagnosed Cancer in the US, 2004-2018.
Nogueira LM; Jemal A; Yabroff KR; Efstathiou JA
JAMA Netw Open; 2022 Apr; 5(4):e229025. PubMed ID: 35476066
[TBL] [Abstract][Full Text] [Related]
6. Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial.
Kim TH; Koh YH; Kim BH; Kim MJ; Lee JH; Park B; Park JW
J Hepatol; 2021 Mar; 74(3):603-612. PubMed ID: 33031846
[TBL] [Abstract][Full Text] [Related]
7. Association of Race With Receipt of Proton Beam Therapy for Patients With Newly Diagnosed Cancer in the US, 2004-2018.
Nogueira LM; Sineshaw HM; Jemal A; Pollack CE; Efstathiou JA; Yabroff KR
JAMA Netw Open; 2022 Apr; 5(4):e228970. PubMed ID: 35471569
[TBL] [Abstract][Full Text] [Related]
8. Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.
Badiyan SN; Rutenberg MS; Hoppe BS; Mohindra P; Larson G; Hartsell WF; Tsai H; Zeng J; Rengan R; Glass E; Katz S; Vargas C; Feigenberg SJ; Simone CB
Pract Radiat Oncol; 2019; 9(4):280-288. PubMed ID: 30802618
[TBL] [Abstract][Full Text] [Related]
9. Patient characterization and usage trends of proton beam therapy for localized prostate cancer in the United States: A study of the National Cancer Database.
Amini A; Raben D; Crawford ED; Flaig TW; Kessler ER; Lam ET; Maroni P; Pugh TJ
Urol Oncol; 2017 Jun; 35(6):438-446. PubMed ID: 28214281
[TBL] [Abstract][Full Text] [Related]
10. Comparative toxicity outcomes of proton-beam therapy versus intensity-modulated radiotherapy for prostate cancer in the postoperative setting.
Santos PMG; Barsky AR; Hwang WT; Deville C; Wang X; Both S; Bekelman JE; Christodouleas JP; Vapiwala N
Cancer; 2019 Dec; 125(23):4278-4293. PubMed ID: 31503338
[TBL] [Abstract][Full Text] [Related]
11. Hadrontherapy for cancer. An overview of HTA reports and ongoing studies.
Jefferson T; Formoso G; Venturelli F; Vicentini M; Chiarolla E; Ballini L
Recenti Prog Med; 2019 Dec; 110(12):566-586. PubMed ID: 31909760
[TBL] [Abstract][Full Text] [Related]
12. Establishing Evidence-Based Indications for Proton Therapy: An Overview of Current Clinical Trials.
Mishra MV; Aggarwal S; Bentzen SM; Knight N; Mehta MP; Regine WF
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):228-235. PubMed ID: 28068231
[TBL] [Abstract][Full Text] [Related]
13. Patterns of Care in Proton Radiation Therapy for Pediatric Central Nervous System Malignancies.
Odei B; Frandsen JE; Boothe D; Ermoian RP; Poppe MM
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):60-63. PubMed ID: 27816365
[TBL] [Abstract][Full Text] [Related]
14. Clinical Outcomes of Proton Beam Therapy for Choroidal Melanoma at a Single Institute in Korea.
Kim TW; Choi E; Park J; Shin DH; Jung SK; Seok S; Cho KH; Kim JY; Kim DY; Kim TH; Suh YK; Kim YJ; Moon SH
Cancer Res Treat; 2018 Apr; 50(2):335-344. PubMed ID: 28421723
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of the cost and cost-effectiveness studies of proton radiotherapy.
Verma V; Mishra MV; Mehta MP
Cancer; 2016 May; 122(10):1483-501. PubMed ID: 26828647
[TBL] [Abstract][Full Text] [Related]
16. Proton therapy expansion under current United States reimbursement models.
Kerstiens J; Johnstone PA
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):235-40. PubMed ID: 24685152
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant Proton Beam Therapy in the Management of Thymoma: A Dosimetric Comparison and Acute Toxicities.
Parikh RR; Rhome R; Hug E; Tsai H; Cahlon O; Chon B; Goenka A
Clin Lung Cancer; 2016 Sep; 17(5):362-366. PubMed ID: 27372386
[TBL] [Abstract][Full Text] [Related]
18. The clinical results of proton beam therapy in patients with idiopathic pulmonary fibrosis: a single center experience.
Ono T; Hareyama M; Nakamura T; Kimura K; Hayashi Y; Azami Y; Hirose K; Hatayama Y; Suzuki M; Wada H; Kikuchi Y; Nemoto K
Radiat Oncol; 2016 Apr; 11():56. PubMed ID: 27090216
[TBL] [Abstract][Full Text] [Related]
19. Differences in Patterns of Care and Referral Between Proton and Photon Therapy.
Hasan S; Verma V; Abel S; Wegner RE; Choi JI; Press RH; Chhabra A; Simone CB
Int J Part Ther; 2024 Mar; 11():100005. PubMed ID: 38757072
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
